Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMO | Q99835 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | MTTP | P55157 | 3/20 | 0.48 |
| ▸ | APOB | P04114 | 2/20 | 0.48 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6795684 | 0.89 | SMO (0.65) | SMOLMNAHTTPOLBTRPV1 | |
| SCHEMBL6798808 | 0.88 | KDR (0.56) | SMOKDRMTTPAPOBGAA | |
| SCHEMBL6793244 | 0.86 | SMO (0.62) | SMOLMNAHTTTRPV1KDR | |
| SCHEMBL6792281 | 0.86 | SMO (0.62) | SMOLMNAHTTTRPV1KDR | |
| SCHEMBL6788033 | 0.86 | SMO (0.67) | SMOLMNAHTTTRPV1KMT2A | |
| SCHEMBL6799294 | 0.86 | KMT2A (0.56) | SMOTRPV1KMT2AKDRMTTP | |
| SCHEMBL6801341 | 0.85 | SMO (0.61) | SMOLMNAHTTTRPV1KDR | |
| SCHEMBL6793814 | 0.84 | SMO (0.59) | SMOLMNAHTTTRPV1KDR | |
| SCHEMBL6795395 | 0.83 | SMO (0.59) | SMOLMNAHTTTRPV1KDR | |
| SCHEMBL6793985 | 0.83 | SMO (0.60) | SMOLMNAHTTTRPV1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | SMO 2094/4885LMNA 1239/4885HTT 2566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.